1200 related articles for article (PubMed ID: 20935617)
1. Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?
Iapichino G; Marzorati S; Umbrello M; Baccalini R; Barassi A; Cainarca M; Colombo Pavini F; Mantovani E; Mauri A; Moroni B; Noto A; Melzi D'Eril GV; Langer M
Minerva Anestesiol; 2010 Oct; 76(10):814-23. PubMed ID: 20935617
[TBL] [Abstract][Full Text] [Related]
2. Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points.
Oberhoffer M; Russwurm S; Bredle D; Chatzinicolaou K; Reinhart K
Intensive Care Med; 2000 Mar; 26 Suppl 2():S170-4. PubMed ID: 18470714
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.
Brunkhorst FM; Wegscheider K; Forycki ZF; Brunkhorst R
Intensive Care Med; 2000 Mar; 26 Suppl 2():S148-52. PubMed ID: 18470710
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis.
Castelli GP; Pognani C; Cita M; Stuani A; Sgarbi L; Paladini R
Minerva Anestesiol; 2006; 72(1-2):69-80. PubMed ID: 16407808
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit.
BalcI C; Sungurtekin H; Gürses E; Sungurtekin U; Kaptanoglu B
Crit Care; 2003 Feb; 7(1):85-90. PubMed ID: 12617745
[TBL] [Abstract][Full Text] [Related]
6. Comparison of procalcitonin and C-reactive protein as markers of sepsis.
Luzzani A; Polati E; Dorizzi R; Rungatscher A; Pavan R; Merlini A
Crit Care Med; 2003 Jun; 31(6):1737-41. PubMed ID: 12794413
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].
Zhao Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287
[TBL] [Abstract][Full Text] [Related]
8. The utility of procalcitonin in critically ill trauma patients.
Sakran JV; Michetti CP; Sheridan MJ; Richmond R; Waked T; Aldaghlas T; Rizzo A; Griffen M; Fakhry SM
J Trauma Acute Care Surg; 2012 Aug; 73(2):413-8; discussion 418. PubMed ID: 22846948
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein.
Pavcnik-Arnol M; Hojker S; Derganc M
Intensive Care Med; 2004 Jul; 30(7):1454-60. PubMed ID: 15127192
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.
Castelli GP; Pognani C; Meisner M; Stuani A; Bellomi D; Sgarbi L
Crit Care; 2004 Aug; 8(4):R234-42. PubMed ID: 15312223
[TBL] [Abstract][Full Text] [Related]
11. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].
Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A
Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of procalcitonin, interleukin-6 and C-reactive protein in the differential diagnosis of patients with sepsis syndrome in intensive care units].
Průcha M; Herold I; Zazula R; Dubská L; Kavka B; Dostál M
Vnitr Lek; 2003 Jul; 49(7):541-7. PubMed ID: 12931436
[TBL] [Abstract][Full Text] [Related]
13. [The study on pro-adrenomedullin as a new biomarker in sepsis prognosis and risk stratification].
Kang FX; Wang RL; Yu KL; Wei Q
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Aug; 20(8):452-5. PubMed ID: 18687169
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6.
Selberg O; Hecker H; Martin M; Klos A; Bautsch W; Köhl J
Crit Care Med; 2000 Aug; 28(8):2793-8. PubMed ID: 10966252
[TBL] [Abstract][Full Text] [Related]
15. [Changes in plasma interleukin-33 concentration in sepsis and its correlation with seriousness of sepsis].
Chang D; Jia J; Zang B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):138-42. PubMed ID: 25665614
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients.
Cheval C; Timsit JF; Garrouste-Orgeas M; Assicot M; De Jonghe B; Misset B; Bohuon C; Carlet J
Intensive Care Med; 2000 Mar; 26 Suppl 2():S153-8. PubMed ID: 18470711
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.
Rey C; Los Arcos M; Concha A; Medina A; Prieto S; Martinez P; Prieto B
Intensive Care Med; 2007 Mar; 33(3):477-84. PubMed ID: 17260130
[TBL] [Abstract][Full Text] [Related]
18. Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response.
Tugrul S; Esen F; Celebi S; Ozcan PE; Akinci O; Cakar N; Telci L
Anaesth Intensive Care; 2002 Dec; 30(6):747-54. PubMed ID: 12500512
[TBL] [Abstract][Full Text] [Related]
19. Discriminative value of inflammatory biomarkers for suspected sepsis.
Tsalik EL; Jaggers LB; Glickman SW; Langley RJ; van Velkinburgh JC; Park LP; Fowler VG; Cairns CB; Kingsmore SF; Woods CW
J Emerg Med; 2012 Jul; 43(1):97-106. PubMed ID: 22056545
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of procalcitonin upon admission to intensive care in the diagnosis and prognosis of sepsis].
Moretti D; Ramírez MM; Settecase CJ; Bagilet DH; Quaglino MB
Med Intensiva; 2013 Apr; 37(3):156-62. PubMed ID: 22658964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]